Mast cells do not contribute to nonsteroidal anti-inflammatory drug-induced gastric mucosal injury in rodents

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 173-180

  Rioux, K P ^a   Wallace, J L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MAST CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; STOMACH MUCOSA INJURY;

EID: 0029967840     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.724116000.x     Document Type: Article

References (32)

1. Wallace JL, McKnight GW, Befus AD. Capsaicin-induced hyperemia in the stomach: possible contribution of mast cells. Am J Physiol 1992; 263: G209-14.
2. Stechschulte DJ, Morris DC, Jilka RL, Stechschulte DJ, Dileepan KN. Impaired gastric acid secretion in mast cell-deficient mice. Am J Physiol 1990; 259: G41-7.
3. Guth PH, Hall P. Microcirculatory and mast cell changes in restraint-induced gastric ulcer. Gastroenterology 1966; 50: 562-70.
4. Galli SJ, Wershil BK, Bose R, Walker PA, Szabo S. Ethanol-induced acute gastric injury in mast cell-deficient and congenic normal mice. Evidence that mast cells can augment the area of damage. Am J Pathol 1988; 128: 131-40.
5. Aceti A, Celestino D, Caferro M, et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology 1991; 101: 131-7.
6. Wallace JL, McKnight GW, Keenan CM, Byles NIA, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990; 98: 1178-86.
7. 4 in mucosal damage caused by necrotizing agents and indomethacin in the rat stomach. Gastroenterology 1991; 100: 619-26.
8. Konturek SJ, Brzozowki T, Drozdowicz D, Garlicki J, Beck G. Role of leukotrienes and platelet-activating factor in acute gastric mucosal lesions in rats. Eur J Pharmacol 1989; 164: 285-92.
9. Wallace JL, Steel G, Whittle BJR, Lagente V, Vargaftig B. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Gastroenterology 1987; 93: 765-72.
10. Franco-Brown S, Masson GMC, Corcoran AC. Induction of acute gastric lesions by histamine liberators in rats: effects thereon of pharmacologie blocking agents. J Allergy 1959; 30: 1-10.
11. Bommelaer G, Guth PH. Protection by histamine receptor antagonists and prostaglandin against gastric mucosal barrier disruption in the rat. Gastroenterology 1979; 77: 303-8.
12. Wallace JL, Cirino G, DeNucci G, McKnight GW. MacNaughton WK. Endothelin has potent ulcerogenic and vasoconstrictor actions in the stomach. Am J Physiol 1989; 256: G661-6.
13. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-4.
14. Santucci L, Fiorucci S, Giansanti M, Brunori PM, Di Matteo FM, Morelli A. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 1994; 35: 909-15.
15. Appleyard CB, McCafferty D-M, Tigley AW, Swain MG, Wallace JL. Tumour necrosis factor mediation of NSAID-induced gastric damage: role of leukocytes. Am J Physiol, in press.
16. Takeuchi K, Ohtsuki H, Okabe S. Pathogenesis of compound 48/80-induced gastric lesions in rats. Dig Dis Sci 1986, 31: 392-400.
17. 2-receptor activation in stress ulceration in rats. Eur J Pharmacol 1979; 55: 23-33.
18. Rioux KP, Wallace JL. Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism. Am J Physiol 1994; 266: G863-9.
19. Beck PL, Morris GP, Wallace JL. Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism. Can J Physiol Pharmacol 1984; 67: 287-93.
20. Takeuchi K, Nishiwaki H, Okabe S. Cytoprotective action of mast cell stabilizers against ethanol-induced gastric lesions in rats. Jpn J Pharmacol 1986; 42: 297-307.
21. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991; 100: 1206-16.
22. Robert A. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77: 433-43.
23. Wallace JL, Tigley AW. New insights into prostaglandins and mucosal defence. Aliment Pharmacol Ther 1995; 9: 227-35.
24. Hogaboam CM, Bissonnette EY, Chin BC, Befus AD, Wallace JL. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993; 104: 122-9.
25. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259: G462-7.
26. Woodbury RG, Miller HRP. Quantitative analysis of mucosal mast cell protease in the intestines of Nippostrongylus-infected rats. Immunology 1982; 46: 487-95.
27. Ennerback L. Mast cells in rat gastrointestinal mucosa. Dye binding and metachromatic properties. Acta Pathol Microbiol Scand 1966; 66: 301-12.
28. Befus AD, Bienenstock J. Immunologically mediated intestinal mastocytosis in Nippostrongylus brasiliensis infected rats. Immunology 1979; 38: 95-101.
29. Soda K, Kawabori S, Perdue MH, Bienenstock J. Macrophage engulfment of mucosal mast cells in rats treated with dexamethasone. Gastroenterology 1991; 100: 929-37.
30. Satoh H, Inada I, Hirata T, Maki Y. Indomethacin produces gastric antral ulcers in the refed rat. Gastroenterology 1981: 719-25.
31. Rainsford KD. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents Actions 1987; 21: 316-9.
32. Reimann HJ, Lewin J, Schmidt U, Wendt P, Blueml G, Dajani EZ. Misoprostol prevents damage to the gastric mucosa by stabilizing the mast cells. Prostaglandins 1987; 33: 105-16.